The Cancer Letter

Inside information on cancer research and drug development

Vol.
23
No.
37
September 26, 1997Sep 26, 1997
Free
DOWNLOAD THE PDF

ODAC Recommends Approval Of Paxen; Will IVAX Break Into $1 Billion Market

In Brief: Lombardi Comprehensive Designation Renewed; Yale Plans Breast Cancer Lab

FDA News: ODAC Clears Photofrin For Microinvasive NSCLC

Report Finds NIH Not At Fault in Case Of P-32 Ingestion

Weinstein Applauds Investigation Report

Cooperative Groups: Insurers Agree To Cover Patient Care Costs In Group Trials

Login

Looking for IP Login?